Drug Type Monoclonal antibody |
Synonyms AM 928, AM928 |
Target |
Mechanism EpCAM inhibitors(Epithelial cell adhesion molecule inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | TW | 14 Jul 2023 | |
Anaplastic Thyroid Carcinoma | Phase 1 | - | - | |
Colorectal Cancer | Phase 1 | - | - | |
Head and Neck Neoplasms | Phase 1 | - | - | |
Nasopharyngeal Neoplasms | Phase 1 | TW | - | |
Esophageal Carcinoma | Preclinical | TW | 01 Dec 2024 |